Aktsiaselts TuleleekRegistered
Key figures
1 616 107 €+2,1%
Revenue 2025
−8,9%
Average annual change 2019–2025
Ratios
2025−0,7%
Profit margin
53,5%
Equity ratio
2,1×
Current ratio
−4,9%
Return on equity
2722 €
Average gross salary
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q2 2026 | 554 283 € | 25 | 110 418 € |
| Q1 2026 | 486 313 € | 56 | 105 211 € |
| Q4 2025 | 600 817 € | 54 | 85 369 € |
| Q3 2025 | 83 077 € | 55 | 100 894 € |
| Q2 2025 | 489 191 € | 35 | 102 810 € |
| Q1 2025 | 436 931 € | 50 | 97 512 € |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Dividends
calculated2025
No dividends were distributed.
History
20250 €
2024100 000 €
2023168 000 €
2022200 001 €
202160 000 €
2020108 001 €
Previous year's retained earnings + previous year's profit − current retained earnings.
Summary of financial statements2019–2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||
| Total current assets | 459 061 | 356 607 | 552 310 | 397 625 | 508 264 | 371 978 | 412 835 |
| Total non-current assets | 17 583 | 14 900 | 24 698 | 27 972 | 22 027 | 16 082 | 17 464 |
| Total assets | 476 644 | 371 507 | 577 008 | 425 597 | 530 291 | 388 060 | 430 299 |
| Balance sheet — liabilities and equity | |||||||
| Current liabilities | 274 933 | 216 404 | 246 570 | 219 870 | 203 125 | 146 652 | 200 121 |
| Non-current liabilities | — | — | — | — | — | — | — |
| Total liabilities | 274 933 | 216 404 | 246 570 | 219 870 | 203 125 | 146 652 | 200 121 |
| Share capital | 26 880 | 26 880 | 26 880 | 26 880 | 26 880 | 26 880 | 26 880 |
| Retained earnings of previous periods | 80 409 | 64 142 | 65 535 | 100 869 | 8159 | 197 598 | 211 840 |
| Profit for the year | 91 734 | 61 393 | 235 335 | 75 290 | 289 439 | 14 242 | −11 230 |
| Reserves and other equity | 2688 | 2688 | 2688 | 2688 | 2688 | 2688 | 2688 |
| Total equity | 201 711 | 155 103 | 330 438 | 205 727 | 327 166 | 241 408 | 230 178 |
| Income statement | |||||||
| Sales revenue | 2 821 418 | 2 475 253 | 2 494 226 | 2 226 959 | 2 455 059 | 1 583 272 | 1 616 107 |
| Operating profit | 115 594 | 82 113 | 245 103 | 117 199 | 314 246 | 27 203 | −12 274 |
| Profit before income tax | 115 594 | 82 113 | 245 103 | 117 267 | 320 741 | 30 521 | −11 230 |
| Profit for the reporting year | 91 734 | 61 393 | 235 335 | 75 290 | 289 439 | 14 242 | −11 230 |
| Labour costs | 1 446 748 | 1 104 640 | 1 116 276 | 1 164 291 | 1 197 955 | 922 745 | 997 455 |
| Depreciation of non-current assets | — | — | — | — | — | — | — |
| Other indicators | |||||||
| Employees | 105 | 91 | 78 | 61 | 54 | 54 | 55 |
| Calculated dividend | — | 108 001 | 60 000 | 200 001 | 168 000 | 100 000 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
CompanyPersonShareholderOther roleAdditional link
Annual reportsPDF, XBRL
Loading list of reports…
Source: e-Business Register (RIK). Files open/download directly from the official register.
Related companies
Same activity — Lepinguline toitlustusteenus jm toitlustamine